Home » Authors » Kim Coghill

Articles by Kim Coghill

Genentech, XOMA Appear Poised For Favorable Word On Raptiva

Sep. 9, 2003

Genentech, XOMA Appear Poised For Favorable Word On Raptiva

Sep. 9, 2003

BIO Files Brief With Court In Support Of Amgen's Position

Sep. 8, 2003

BIO Files Brief With Court In Support Of Amgen's Position

Sep. 8, 2003

Theratechnologies Enters Deal With J&J In Area Of Diabetes

Sep. 5, 2003

Cerus, Baxter Stop Phase III Of S-303 In Precautionary Move

Sep. 5, 2003

Theratechnologies Enters Deal With J&J In Area Of Diabetes

Sep. 5, 2003

Cerus, Baxter Stop Phase III Of S-303 In Precautionary Move

Sep. 5, 2003

FDA Puts Clinical Hold On Two Trials Of Antigenics' Oncophage

Sep. 4, 2003

FDA Puts Clinical Hold On Two Trials Of Antigenics' Oncophage

Sep. 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...